Path Traversal Vulnerability in Suprema BioStar 2 by Suprema Inc.
CVE-2023-33365

7.5HIGH

Key Information:

Vendor

Supremainc

Status
Biostar 2
Vendor
CVE Published:
3 August 2023

What is CVE-2023-33365?

A path traversal vulnerability has been identified in Suprema BioStar 2 prior to version 2.9.1. This flaw enables unauthenticated attackers to exploit the server's web interface, allowing them to retrieve arbitrary files. As a result, sensitive information stored on the server becomes accessible, posing significant risks to data integrity and privacy.

References

https://kb.supremainc.com/knowledge/doku.php?id=en:releas...
https://claroty.com/team82/disclosure-dashboard/cve-2023-...

CVSS V3.1

Score:
7.5
Severity:
HIGH
Confidentiality:
High
Integrity:
None
Availability:
High
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
None
User Interaction:
None
Scope:
Unchanged

Timeline

  • Vulnerability published

  • Vulnerability Reserved

.